NOS2 Antibodies

Santa Cruz Biotechnology features a diverse variety of NOS2 monoclonal antibodies for nitric oxide synthase 2 (NOS2) research. NOS2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NOS2, also known as inducible nitric oxide synthase, plays a critical role in the immune response by producing nitric oxide, a signaling molecule involved in various physiological and pathological processes. Its regulation is essential for controlling inflammation and responding to pathogens, making NOS2 a significant target in studies related to immune function and disease mechanisms. Understanding NOS2 can provide insights into therapeutic strategies for conditions such as sepsis, cancer, and neurodegenerative diseases. Researchers can explore the molecular mechanisms of nitric oxide production and its impact on cellular signaling pathways. The role of NOS2 in inflammation and immune response continues to be an active area of investigation in biomedical research. Investigating NOS2 expression patterns helps reveal its involvement in various disease states and potential therapeutic interventions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of NOS2 and its implications in human health and disease.